Hologic Inc (STU:HO1)
€ 72 -4.5 (-5.88%) Market Cap: 16.83 Bil Enterprise Value: 17.02 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 06:10PM GMT
Release Date Price: €48 (+1.27%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Greetings. This is Dan Brennan. UBS' Life Science Tools Diagnostics Pharma Services analyst. It's day 1 of our virtual health care conference. In the 2:10 slot, and I'm pleased to be joined with me, Mike Watts, who is VP of Investor Relations and Corporate Communications at Hologic.

So for those of you who are online, feel free to send the question to me that way, I think there is a way to submit questions. And certainly, during the presentation, I'll allot some time towards the middle, or back end, and we'll hopefully get to some of those questions. And I think to kick it off, I think Mike is going to make some opening remarks, and then we'll dig into some Q&A. So Mike, thanks for joining us.

Michael J. Watts
Hologic, Inc. - VP of IR & Corporate Communications

Yes. Thank you, Dan. Thanks for having us. Really appreciate the opportunity to join you for your virtual conference. So thanks again.

Yes. So Hologic,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot